(Q28245267)

English

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement

scientific article (publication date: May 2005)

In more languages

Statements

scholarly article

0 references

Pharmacokinetic profile of the oral direct thrombin inhibitor dabigatran etexilate in healthy volunteers and patients undergoing total hip replacement (English)

0 references

0 references

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

object named as

Gerhard Nehmiz

5

0 references

author name string

Joachim Stangier

1

0 references

Bengt I Eriksson

2

0 references

Ola E Dahl

3

0 references

Lennart Ahnfelt

4

0 references

Hildegard Stähle

6

0 references

Karin Rathgen

7

0 references

Robbyna Svärd

8

0 references

language of work or name

0 references

publication date

May 2005

0 references

The Journal of Clinical Pharmacology

0 references

45

0 references

555-63

0 references

5

0 references

Management of venous thromboembolism: past, present, and future

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Structure-based design of novel potent nonpeptide thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I.

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies.

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement: the METHRO II randomised trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement.

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.

1 reference

https://api.crossref.org/works/10.1177%2F0091270005274550

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28245267&oldid=1517080471"